Cure SMA logo
Cure SMA Basic Research Program

Cure SMA Basic Research Grant

Funds novel research on spinal muscular atrophy biology and drug target identification worldwide.

Between cyclesCure SMAGlobal

Cure SMA is a US-based 501(c)(3) patient advocacy foundation (EIN: 36-3320440, headquartered in Schaumburg, Illinois) that has invested over $82 million in spinal muscular atrophy research since 1984, including more than $15 million across 128 basic research grants. Its annual Basic Research Grant programme funds novel scientific investigation into SMA biology, with the explicit goal of identifyin

Novel research on SMA biology: disease pathology, drug target identification, therapeutic strategies, reagents/tools for drug development and clinical trials.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.12–24 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$750K

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Last verified: 22 Jul 2026Source: www.curesma.org